Search

Your search keyword '"Lafontaine, Jennifer"' showing total 116 results

Search Constraints

Start Over You searched for: Author "Lafontaine, Jennifer" Remove constraint Author: "Lafontaine, Jennifer"
116 results on '"Lafontaine, Jennifer"'

Search Results

1. Spatiotemporal immune atlas of a clinical-grade gene-edited pig-to-human kidney xenotransplant

3. Acute kidney injury results in long-term alterations of kidney lymphatics in mice.

5. Cognate antigen-independent differentiation of resident memory T cells in chronic kidney disease.

8. Design and Synthesis of Functionally Active 5-Amino-6-Aryl Pyrrolopyrimidine Inhibitors of Hematopoietic Progenitor Kinase 1

9. Spatiotemporal immune atlas of the first clinical-grade, gene-edited pig-to-human kidney xenotransplant

10. Resident macrophage subpopulations occupy distinct microenvironments in the kidney

14. Airway Remodeling in Ferrets with Cigarette Smoke Induced COPD using µCT Imaging Supplement File

16. Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)

17. Abstract B25: Development of a nanoparticle containing the PI3K/mTOR dual Inhibitor, gedatolisib, for cancer therapy

20. Discovery of a novel class of targeted kinase inhibitors that blocks protein kinase C signaling and ameliorates retinal vascular leakage in a diabetic rat model☆

21. Synthesis and diastereoslective complexation of enantiopure sulfinyl dienes: The preparation of sulfinyl iron(O) dienes

22. From the story circle to cyberspace

23. Excess mucus viscosity and airway dehydration impact COPD airway clearance

26. Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR

27. Enantioselective total synthesis of the antitumor macrolide rhizoxine D

28. Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants

29. Abstract 2594: Characterization of a novel irreversible third generation EGFR TKI that targets T790M-mediated resistant EGFR-mutant NSCLC while sparing wild type EGFR

30. Design, Synthesis, and Evaluation of NO-Donor Containing Carbonic Anhydrase Inhibitors To Lower Intraocular Pressure

32. Contrôle de l'expression des gènes ribosomaux chez la levure et l'homme

37. 'From the Story Circle to Cyberspace.'

38. Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity

46. Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity

48. Effect of PF-04217329 a prodrug of a selective prostaglandin EP2 agonist on intraocular pressure in preclinical models of glaucoma

49. Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of Cancer.

50. Alcohol-Induced Mucociliary Dysfunction: Role of Defective CFTR Channel Function.

Catalog

Books, media, physical & digital resources